Healthcare News

US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs; call for doctors to switch patients with mild to moderate symptoms to Entresto[1] Updated...

TORONTO, ON--(Marketwired - May 20, 2016) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES PharmaCan Capital Corp. ("PharmaCan" or the "Company")...

MIAMI, May 20, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on May 19, 2016, the Company...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} FIT BIOTECH OYYHTIÖTIEDOTE 20.5.2016FIT...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} FIT BIOTECH OYCOMPANY RELEASE 20 May...

SAN DIEGO, May 20, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...

AUSTIN, Texas, May 20, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid...

Gereglementeerde informatie Waregem (België)/Rotterdam (Nederland)[1], 20 mei 2016 Fagron maakt vandaag bekend dat de kapitaalverhoging met opheffing van het voorkeurrecht van de bestaande...

Regulated informationWaregem (Belgium)/Rotterdam (The Netherlands)[1], 20 May 2016 Fagron announces today that the capital increase with cancellation of the preferential subscription rights of the...

Highlights: Q1 2016 revenues rise to approximately $161,000 from zero in year-ago quarterQ1 2016 net loss narrows by approximately $1.6 million year over yearQ1 2016 operating expenses continued to...